PCC probiomics limited

eoy report out

  1. 1,177 Posts.
    After a quick look, initial thoughts included that rev hasn't gone throught the roof, expenditure has been controlled but not sure Admin & Corp Expenses at $1.6m and marketing expenses at $340k when PCC don't appear to be penetrating the market as yet. Other concern, although half expected, is the line 'Although the company completed an capital raising of $1,025,000 in August 2006, its ability to continue as a going concernis dependant on it generating sufficient incometo cover costsand the completion of an additionalcapital rasing within the coming months.'

    All in all though, not that interested in past results as we have been forewarned of the teething problems. An exciting 6-12 months lay ahead.

    Anyone able to gain anything else from the annual report?
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.